Changes of mRNA expression underlying orbital adipogenesis in thyroid-associated orbitopathy
Open Access
- 6 October 2022
- journal article
- letter
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 18 (6) , 1708-1715
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signalingThe FASEB Journal, 2012
- Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid diseaseBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathyJournal of Clinical Pathology, 2012
- Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular DegenerationJournal of Translational Medicine, 2011
- Gene Expression in Graves' Ophthalmopathy and Arm Lymphedema: Similarities and DifferencesThyroid®, 2011
- Graves' OphthalmopathyNew England Journal of Medicine, 2010
- Complement C5 Mediates Experimental Tubulointerstitial FibrosisJournal of the American Society of Nephrology, 2007
- ROLE OF C5A IN INFLAMMATORY RESPONSESAnnual Review of Immunology, 2005
- Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic PhenotypesThe American Journal of Pathology, 2003
- Immunohistochemical study of intrathyroidal lymph folliclesClinical Immunology and Immunopathology, 1987